CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 146 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,800,459 | -11.1% | 1,437,165 | +2.2% | 0.00% | -25.0% |
| Q2 2023 | $18,908,777 | -18.1% | 1,406,903 | +1.0% | 0.00% | -20.0% |
| Q1 2023 | $23,090,221 | -11.0% | 1,392,655 | -0.1% | 0.01% | 0.0% |
| Q4 2022 | $25,934,240 | +47.9% | 1,394,314 | +2.0% | 0.01% | +25.0% |
| Q3 2022 | $17,536,000 | +90.1% | 1,366,861 | +3.9% | 0.00% | +100.0% |
| Q2 2022 | $9,226,000 | -15.7% | 1,316,132 | -0.3% | 0.00% | 0.0% |
| Q1 2022 | $10,942,000 | +17.3% | 1,319,893 | -4.2% | 0.00% | 0.0% |
| Q4 2021 | $9,332,000 | +23.5% | 1,378,440 | -3.3% | 0.00% | +100.0% |
| Q3 2021 | $7,557,000 | -7.7% | 1,425,703 | +0.1% | 0.00% | 0.0% |
| Q2 2021 | $8,189,000 | +51.3% | 1,424,148 | +21.3% | 0.00% | 0.0% |
| Q1 2021 | $5,412,000 | +29.3% | 1,174,173 | -6.2% | 0.00% | 0.0% |
| Q4 2020 | $4,184,000 | +6.0% | 1,252,341 | -5.8% | 0.00% | 0.0% |
| Q3 2020 | $3,949,000 | -38.0% | 1,329,631 | -3.6% | 0.00% | -50.0% |
| Q2 2020 | $6,370,000 | +34.4% | 1,378,700 | +12.0% | 0.00% | +100.0% |
| Q1 2020 | $4,739,000 | +2.3% | 1,230,963 | -0.4% | 0.00% | 0.0% |
| Q4 2019 | $4,634,000 | -26.7% | 1,235,921 | +3.8% | 0.00% | -50.0% |
| Q3 2019 | $6,323,000 | +42.3% | 1,190,912 | +2.9% | 0.00% | +100.0% |
| Q2 2019 | $4,444,000 | -22.7% | 1,157,742 | +2.7% | 0.00% | 0.0% |
| Q1 2019 | $5,749,000 | +165.3% | 1,127,344 | -0.1% | 0.00% | 0.0% |
| Q4 2018 | $2,167,000 | -50.3% | 1,128,641 | -2.2% | 0.00% | 0.0% |
| Q3 2018 | $4,363,000 | +26.2% | 1,154,338 | +4.2% | 0.00% | 0.0% |
| Q2 2018 | $3,458,000 | +43.2% | 1,107,944 | +9.7% | 0.00% | 0.0% |
| Q1 2018 | $2,414,000 | -25.1% | 1,009,947 | +22.5% | 0.00% | 0.0% |
| Q4 2017 | $3,223,000 | +57.6% | 824,308 | +1.6% | 0.00% | 0.0% |
| Q3 2017 | $2,045,000 | -7.7% | 811,513 | +1.1% | 0.00% | 0.0% |
| Q2 2017 | $2,215,000 | +920.7% | 802,566 | +620.9% | 0.00% | – |
| Q1 2017 | $217,000 | +106.7% | 111,328 | +10.9% | 0.00% | – |
| Q4 2016 | $105,000 | -24.5% | 100,396 | -21.3% | 0.00% | – |
| Q3 2016 | $139,000 | +117.2% | 127,584 | +41.2% | 0.00% | – |
| Q2 2016 | $64,000 | -92.8% | 90,367 | -88.2% | 0.00% | – |
| Q1 2016 | $893,000 | -52.3% | 763,820 | -0.0% | 0.00% | -100.0% |
| Q4 2015 | $1,873,000 | -18.2% | 764,108 | +0.1% | 0.00% | 0.0% |
| Q3 2015 | $2,291,000 | +289.6% | 763,513 | +436.4% | 0.00% | – |
| Q2 2015 | $588,000 | +40.7% | 142,328 | +47.6% | 0.00% | – |
| Q1 2015 | $418,000 | +45.1% | 96,429 | -0.5% | 0.00% | – |
| Q4 2014 | $288,000 | -3.0% | 96,954 | +8.4% | 0.00% | – |
| Q3 2014 | $297,000 | +28.0% | 89,414 | -2.4% | 0.00% | – |
| Q2 2014 | $232,000 | +33.3% | 91,642 | +19.3% | 0.00% | – |
| Q1 2014 | $174,000 | +34.9% | 76,786 | +16.3% | 0.00% | – |
| Q4 2013 | $129,000 | -24.6% | 66,043 | +18.2% | 0.00% | – |
| Q3 2013 | $171,000 | +350.0% | 55,885 | +30.2% | 0.00% | – |
| Q2 2013 | $38,000 | – | 42,906 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |